Pages that link to "Q35833088"
Jump to navigation
Jump to search
The following pages link to Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. (Q35833088):
Displaying 50 items.
- p63 is a prostate basal cell marker and is required for prostate development (Q24290591) (← links)
- EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance (Q24646417) (← links)
- Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer (Q24673693) (← links)
- Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells (Q24685483) (← links)
- U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. (Q24811943) (← links)
- Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer Cells (Q26795738) (← links)
- Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions (Q28343497) (← links)
- Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer (Q28709995) (← links)
- Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer (Q33236893) (← links)
- Molecular staging of prostate cancer in the year 2007. (Q33276580) (← links)
- A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors (Q33379466) (← links)
- Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention (Q33608788) (← links)
- An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer (Q34066960) (← links)
- The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy (Q34092523) (← links)
- Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities (Q34139691) (← links)
- Bcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis. (Q34193061) (← links)
- c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine (Q34225131) (← links)
- Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. (Q34252079) (← links)
- Estrogen receptor beta in prostate cancer: brake pedal or accelerator? (Q34299700) (← links)
- Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression (Q34397291) (← links)
- Regulation of cell survival and death during Flavivirus infections (Q34424352) (← links)
- Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer (Q34722249) (← links)
- D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections. (Q34790475) (← links)
- Immunopathological prognostic and predictive factors in prostate cancer (Q35054043) (← links)
- Antisense Bcl-2 sensitizes prostate cancer cells to radiation (Q35062101) (← links)
- Apoptotic cell signaling in cancer progression and therapy (Q35088734) (← links)
- Angiogenin as a Molecular Target for the Treatment of Prostate Cancer (Q35090356) (← links)
- Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes (Q35142325) (← links)
- Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis (Q35167933) (← links)
- Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer (Q35352194) (← links)
- c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle (Q35538874) (← links)
- Genetic alterations in hormone-refractory recurrent prostate carcinomas (Q35753171) (← links)
- A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer. (Q35754996) (← links)
- Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers (Q35773657) (← links)
- Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma (Q35798545) (← links)
- Bcl-2 expression in normal endometrium during the menstrual cycle. (Q35834144) (← links)
- Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. (Q35834262) (← links)
- Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. (Q35839316) (← links)
- Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer (Q35873154) (← links)
- Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. (Q35946094) (← links)
- Correlation study of Bcl-2, B7-H1, EGFR, VEGF and colorectal cancer (Q35993161) (← links)
- Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer (Q36050408) (← links)
- Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer (Q36072084) (← links)
- Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer (Q36080901) (← links)
- Expression and prognostic significance of Bcl-2 in ovarian tumours (Q36081344) (← links)
- Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas. (Q36116339) (← links)
- Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance (Q36254793) (← links)
- Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma (Q36358045) (← links)
- Bcl-2-family proteins and hematologic malignancies: history and future prospects (Q36508817) (← links)
- Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus (Q36620483) (← links)